AffiNANOTECH® Ladiratuzumab
CAT# AFG-MCX-1356
Size: 100 mg
Availables Sizes: 1 mg, 5 mg, 10 mg, 50 mg, 100 mg.
Overview
Ladiratuzumab (hLIV22) is an anti-LIV-1/ZIP6humanized monoclonal antibody. Ladiratuzumab, conjugated with the microtubule disrupting agent, MMAE (HY-15162) to compose SGN-LIV1A, anantibody-drug conjugate (ADC) . Ladiratuzumab can be used for research of breastcancer.
Isotype
Human IgG1 kappa.
Species
Humanized.
Target
N/A.
Appearance
Liquid.
Shipping Conditions
Dry Ice.
Storage Conditions
Store the product under the recommended conditions in the Certificate of Analysis.